Washington Trust’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10
Closed -$1K 974
2021
Q4
$1K Sell
10
-9
-47% -$576 ﹤0.01% 907
2021
Q3
$1K Hold
19
﹤0.01% 1025
2021
Q2
$1K Sell
19
-3
-14% -$112 ﹤0.01% 1012
2021
Q1
$1K Sell
22
-3
-12% -$107 ﹤0.01% 970
2020
Q4
$1K Sell
25
-4
-14% -$116 ﹤0.01% 950
2020
Q3
$1K Sell
29
-25
-46% -$617 ﹤0.01% 938
2020
Q2
$1K Sell
54
-58
-52% -$1K ﹤0.01% 828
2020
Q1
$1K Buy
+112
New +$1.88K ﹤0.01% 904

Other funds holding MXL

Washington Trust's MXL Position: Q1 2022 in Review

Washington Trust sold out of MaxLinear (MXL) in Q1 2022, closing a stake of 10 shares — an estimated $1K sold.

Washington Trust first reported a position in MXL in Q1 2020 and held it in 8 quarters. The position peaked at $1K in Q4 2021. 293 funds tracked by Wall St. Rank hold MXL as of Q1 2022.

  • Washington Trust reported no remaining MaxLinear position as of Q1 2022 after selling out during the quarter.
  • Washington Trust sold 10 MaxLinear shares in Q1 2022, an estimated $1K.
  • Washington Trust first reported a position in MaxLinear in Q1 2020 and held it in 8 quarters.
  • Washington Trust's MaxLinear position peaked at $1K in Q4 2021.
  • 293 funds tracked by Wall St. Rank held MaxLinear as of Q1 2022.

Based on Washington Trust's 13F filing for Q1 2022, filed 5 May 2022.